Unlocking adherence: is gender the key?

Lancet HIV. 2015 Jan;2(1):e2-3. doi: 10.1016/S2352-3018(14)00033-2. Epub 2014 Dec 11.

Authors

Cathy Puskas¹, Robert S Hogg²

Affiliations

¹ Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada; BC Centre for Excellence in HIV/AIDS, Vancouver, BC V6Z 1Y6, Canada.
² Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada; BC Centre for Excellence in HIV/AIDS, Vancouver, BC V6Z 1Y6, Canada. Electronic address: bobhogg@cfenet.ubc.ca.

PMID: 26424233
DOI: 10.1016/S2352-3018(14)00033-2

No abstract available

Publication types

Comment

MeSH terms

Anti-HIV Agents / administration & dosage*
Antiretroviral Therapy, Highly Active*
Female
HIV Infections / drug therapy*
Humans
Male
Medication Adherence / psychology*

Substances

Anti-HIV Agents